Company: CLX
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0000021076-25-000053
Chunk: 17

Company: CLOROX CO /DE/
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 1
Chunk 17
---
(1)Other segment items includes selling, general and administrative expenses, advertising costs, research and development costs and other income and expenses. The charges defined in segment adjusted EBIT above are excluded from other segment items and Corporate and Other.(2)Represents expenses related to the Company’s digital capabilities and productivity enhancements investment corresponding to Corporate and Other.  

16

NOTE 12. SEGMENT RESULTS (Continued)

Segment adjusted earnings (losses) before interest and income taxesThree months ended September 30, 2024Health and WellnessHouseholdLifestyleInternationalTotalNet sales$698 $447 $320 $259 Cost of products sold322 289 157 158 Other segment items (1)141 98 97 66 Segment adjusted EBIT$235 $60 $66 $35 $396 Corporate and Other (64)Interest income3 Interest expense(21)Loss on divestiture (2)(118)Cyberattack costs, net of insurance recoveries (3)10 Digital capabilities and productivity enhancements investment (4)(29)Earnings before income taxes$177 (1)Other segment items includes selling, general and administrative expenses, advertising costs, research and development costs and other income and expenses. The charges defined in segment adjusted EBIT above are excluded from other segment items and Corporate and Other.(2)Represents the loss on divestiture of the Better Health VMS business corresponding to Corporate and Other. See Note 3 for additional details related to the divestiture.(3)Represents insurance recoveries related to the cyberattack corresponding to Corporate and Other. See Note 9 for further discussion. (4)Represents expenses related to the Company’s digital capabilities and productivity enhancements investment corresponding to Corporate and Other.Certain other segment disclosures were as follows:Health and WellnessHouseholdLifestyleInternationalCorporate and OtherTotalCompanyTotal assetsBalance as of 9/30/2025$1,161 $1,060 $1,108 $1,318 $881 $5,528 Balance as of 6/30/20251,217 1,091 1,103 1,329 821 5,561 (Income) Loss from equity investees included in Other (income) expense, netThree months ended 9/30/2025— — — (1)— (1)Three months ended 9/30/2024— — —